Back to results
US 2021/0069199 A1Published application
Methods of treating transplant rejection
OwnerBrian C. Betts, Xuezhong Yu +1inventors
InventorsBrian C. Betts, Xuezhong Yu, Claudio Anasetti
Life of this patent
Estimating the term…
Abstract
The present invention provides the use of protein kinase inhibitors, in particular JAK2 inhibitors of formula (I), as set forth in the specification, in the treatment of solid organ transplant rejection and graft versus host disease (GvHD). Also provided are combination therapies for the treatment of solid organ transplant rejection and graft versus host disease.
Claims12
A method of treating graft versus host disease (GvHD) in a mammal comprising administration to a mammal in need thereof of a therapeutically effective amount of a compound of Formula (I):
- wherein:
- R1 and R2 are H;
- Z2 is —N(H)—;
- Ar1 is selected from the group consisting of:
- wherein R10 is methoxy or fluorine;
- (ii) k is an integer selected from 0 or 1;
- Ar2 is a group of the formula
- wherein R11 is H or selected from the group consisting of:
- L is a group of formula:
- —X1—Y—X2—
- wherein X1 is attached to Ar1 and X2 is attached to Ar2, and wherein X1, X2 and Y are selected such that the group L has between 5 and 15 atoms in the normal chain,
- wherein X1 is selected from the group consisting of:
- (a) —OCH2—
- (b) —OCH2CH2—, and
- (c) —CH2OCH2—;
- wherein X2 is selected from the group consisting of:
- (a) —CH2O—,
- (b) —CH2CH2O—, and
- (c) —CH2OCH2—;
- Y is a group of formula —CRa═CRb—,
- wherein Ra and Rb are H,
- or a pharmaceutically acceptable salt or N-oxide thereof,
- wherein the mammal has received or is currently receiving an allogeneic bone marrow or hematopoietic stem cell transplant.
20 more elements
Dependencies are inferred from the claim text.